Tutorials › Causal Inference › Why Relevance Does Not Establish Instrument Validity

Instrumental Variable Assumptions and Estimands · Tutorial 506 of 972

Why Relevance Does Not Establish Instrument Validity

Learn why strong instrument–treatment association is only a relevance condition, and how independence, exclusion, and monotonicity can fail despite it.

Intermediate 10 min read

What You'll Learn

  • Define relevance as a nonzero contrast in treatment rates across instrument levels.
  • Distinguish relevance from independence, exclusion, and monotonicity.
  • Trace how confounding can create a strong first stage and a misleading reduced form.
  • Calculate how a direct instrument effect can distort a Wald ratio.
  • See how a strong first stage can coexist with defiers and an uninformative Wald ratio.
  • Explain why relevance alone cannot establish instrument validity.

Relevance Is One Requirement, Not a Validity Test

An instrument that strongly predicts treatment may seem persuasive: people receiving one level of the instrument are much more likely to receive treatment than people receiving the other. That pattern is important, because without a treatment contrast induced by the instrument, an instrumental-variable comparison has no leverage. But a strong first stage answers only whether the instrument and treatment are associated. It does not establish why they are associated, whether the instrument also affects the outcome through another route, or whether treatment responses move in the required direction for every individual.

For a binary instrument \(Z\) and binary treatment \(D\), relevance is commonly summarized by the first-stage contrast \(E[D\mid Z=1]-E[D\mid Z=0]\). The contrast can be large even when other conditions needed for an instrumental-variable interpretation fail. The counterexamples below hold relevance strong while violating, in turn, independence, exclusion, and monotonicity.

Definition: Let \(D(z)\) denote the treatment an individual would receive if the instrument were set to \(z\), and let \(Y(d)\) denote the outcome if treatment were set to \(d\). For a binary instrument, relevance means that the instrument changes treatment receipt in the population; one measure is \(E[D\mid Z=1]-E[D\mid Z=0]\ne 0\). Common assumptions used to interpret an instrumental-variable comparison are independence, \(Z\perp (Y(0),Y(1),D(0),D(1))\); exclusion, meaning the outcome under instrument level \(z\) and treatment level \(d\), \(Y(z,d)\), equals \(Y(d)\); and monotonicity, \(D(1)\ge D(0)\) for every individual. These are distinct conditions: relevance does not imply any of them.

The independence condition says, in effect, that instrument assignment does not sort individuals according to their potential treatments or outcomes. Exclusion says that changing the instrument cannot change the outcome except by changing treatment. Monotonicity rules out individuals whose treatment would move in the opposite direction from the instrument. These are claims about assignment mechanisms, causal pathways, or individual responses—not merely about observed differences in treatment rates.

A Strong First Stage Can Accompany Dependence

In an observational setting, an instrument may be strongly associated with treatment because both are related to a third variable. The resulting association says little by itself about whether the instrument is independent of potential outcomes. The first example makes this distinction explicit.

Worked Example: A Confounded Instrument With a Perfect First Stage

Suppose a hypothetical population has a binary characteristic \(U\), with \(P(U=1)=0.5\). An observational instrument \(Z\) is more likely to equal 1 when \(U=1\): \(P(Z=1\mid U=1)=0.9\), compared with \(P(Z=1\mid U=0)=0.1\). Treatment follows the instrument exactly, so \(D=Z\). The outcome is \(Y=U\), regardless of treatment. In particular, treatment has no causal effect.

The instrument occurs with probability \(P(Z=1)=0.9(0.5)+0.1(0.5)=0.5\). Bayes' rule gives \(P(U=1\mid Z=1)=0.9(0.5)/0.5=0.9\), while \(P(U=1\mid Z=0)=0.1(0.5)/0.5=0.1\). Because \(D=Z\), the first-stage contrast is

$$ E[D\mid Z=1]-E[D\mid Z=0]=1-0=1. $$

This is the largest possible first-stage contrast for a binary treatment. Yet the outcome contrast is also large:

$$ E[Y\mid Z=1]-E[Y\mid Z=0]=0.9-0.1=0.8. $$

The treatment effect is zero because \(Y=U\) under either treatment level. The outcome contrast arises because \(Z\) is associated with \(U\), which determines the outcome. Thus independence fails: the instrument is not independent of the potential outcomes. The example shows that even a perfect first stage does not remove confounding of the instrument–outcome comparison.

In this construction, exclusion and monotonicity can hold: the outcome has no direct dependence on \(Z\), and \(D(1)=1\ge 0=D(0)\) for everyone. Failure of independence alone is enough to undermine the causal interpretation. A strong observed treatment-rate contrast cannot reveal whether assignment was as-if random with respect to potential outcomes.

A Strong First Stage Can Coexist With an Outcome Pathway

Even if instrument assignment is randomized and treatment responds monotonically, the instrument may affect the outcome through a route other than the treatment under study. That possibility is what exclusion rules out. Relevance does not assess it.

Worked Example: A Direct Instrument Effect Distorts the Wald Ratio

Consider a hypothetical randomized binary instrument \(Z\), with \(P(Z=1)=0.5\). Suppose every individual receives \(D=Z\), so everyone is a complier and the first-stage contrast is 1. Let the outcome, measured in score points, be \(Y(d,z)=2d+5z\). This equation specifies an outcome of 2 points per treatment unit and an additional 5 points when the instrument is set to 1.

Assignment is independent of potential outcomes and treatment responses, and monotonicity holds because \(D(1)=1\ge D(0)=0\) for everyone. But exclusion fails: holding treatment fixed, changing the instrument from 0 to 1 changes the outcome by 5 points. The treatment effect at either fixed instrument level is only 2 points.

The observed treatment means are \(E[D\mid Z=1]=1\) and \(E[D\mid Z=0]=0\). The observed outcome means are \(E[Y\mid Z=1]=2(1)+5(1)=7\) points and \(E[Y\mid Z=0]=2(0)+5(0)=0\) points. The Wald ratio is therefore

$$ \frac{E[Y\mid Z=1]-E[Y\mid Z=0]} {E[D\mid Z=1]-E[D\mid Z=0]} = \frac{7-0}{1-0} =7\text{ points per treatment unit}. $$

The causal effect of treatment is 2 points per treatment unit, not 7. The extra 5 points come directly from the instrument. Here relevance is perfect, but the ratio does not isolate the effect of treatment because exclusion fails.

Randomization addresses independence; it does not guarantee exclusion. An instrument can be assigned independently and still change the outcome through, for example, additional services, attention, or behavior that is not represented by the treatment definition. Whether such pathways are plausible requires substantive knowledge of how the instrument operates, not inspection of the first-stage contrast alone.

A Strong First Stage Can Hide Defiers

Monotonicity is an individual-level condition. A positive, even substantial, average treatment-rate difference does not show that every individual responds in the same direction. Some individuals may be compliers, with \(D(1)=1\) and \(D(0)=0\); others may be defiers, with \(D(1)=0\) and \(D(0)=1\). Their responses can coexist with a strong positive first stage if compliers are more numerous.

Worked Example: A Positive First Stage but a Negative Wald Ratio

Suppose a hypothetical population consists of 70% compliers, 20% defiers, and 10% never-takers. The instrument is randomized independently of these types and of potential outcomes. Exclusion holds, with potential outcomes \(Y(0)=0\) for everyone; treatment effects are 1 point for compliers, 4 points for defiers, and 0 points for never-takers.

Under \(Z=1\), the 70% of compliers receive treatment and the defiers and never-takers do not, so \(E[D\mid Z=1]=0.70\). Under \(Z=0\), only the 20% of defiers receive treatment, so \(E[D\mid Z=0]=0.20\). The first-stage contrast is

$$ 0.70-0.20=0.50. $$

For the outcome, the mean under \(Z=1\) is \(0.70(1)+0.20(0)+0.10(0)=0.70\) points. Under \(Z=0\), it is \(0.70(0)+0.20(4)+0.10(0)=0.80\) points. Therefore the reduced-form outcome contrast and the Wald ratio are

$$ E[Y\mid Z=1]-E[Y\mid Z=0]=0.70-0.80=-0.10\text{ points}, $$
$$ \frac{-0.10}{0.50}=-0.20\text{ points per treatment unit}. $$

The first stage is positive and substantial, while the Wald ratio is negative. This does not mean that the treatment effect for compliers is negative: in this population it is 1 point. Defiers both reduce the first-stage contrast and contribute an outcome contrast in the opposite direction. Monotonicity fails, so the usual interpretation of the Wald ratio as the complier average causal effect does not follow.

Why the Conditions Must Be Assessed Separately

The algebra clarifies the role of monotonicity in the last example. With a randomized binary instrument and exclusion, the first-stage contrast is the proportion of compliers minus the proportion of defiers. The outcome contrast is the complier share times their average treatment effect minus the defier share times their average treatment effect. If the first-stage contrast is nonzero, their ratio is

$$ \frac{ P(C)\,E[Y(1)-Y(0)\mid C] - P(F)\,E[Y(1)-Y(0)\mid F] }{ P(C)-P(F) }, $$

where \(C\) denotes the complier group and \(F\) the defier group. This expression follows because assignment changes treatment from 0 to 1 for compliers and from 1 to 0 for defiers; never-takers and always-takers contribute no assignment-induced treatment change. Under monotonicity, \(P(F)=0\), leaving the complier average treatment effect. Without it, a nonzero denominator alone does not give that interpretation. The example's contrast is \((0.70(1)-0.20(4))/(0.70-0.20)=-0.20\), as calculated.

Relevance is observable from treatment rates across instrument levels, but it is only one part of an instrumental-variable argument. Independence concerns how the instrument is assigned relative to potential outcomes and treatments. Exclusion concerns causal pathways from the instrument to the outcome. Monotonicity concerns the joint potential treatment responses of individuals, which are not both observed for any one person. A large first-stage contrast does not directly verify any of these claims.

Key takeaway: Relevance establishes that the instrument predicts treatment in the population. It does not establish that the instrument is independent of potential outcomes, that it affects the outcome only through treatment, or that no individual responds in the opposite direction. An instrumental-variable interpretation requires separate support for each assumption it uses.

Common Mistake

A common mistake is to reason, “The treatment rate differs sharply by instrument level, so the instrument is valid.” The first clause establishes relevance, not validity. The first example has a perfect first stage but a confounded instrument; the second has a perfect first stage but a direct outcome effect; the third has a substantial first stage but defiers. A more defensible conclusion is that the instrument is relevant, while independence, exclusion, and monotonicity require their own design-based or substantive justification. A weak first stage can be a problem, but a strong first stage cannot certify the other assumptions.

Check Your Understanding

For each question, distinguish the evidence supplied by the first stage from the additional assumptions needed for a causal interpretation.

  1. In the first example, why is the outcome contrast not evidence that treatment caused the outcome to change?
  2. In the second example, which assumption fails, and how many of the 7 score points in the Wald ratio are due to the direct instrument pathway?
  3. In the third example, calculate the first-stage contrast from the treatment rates under \(Z=1\) and \(Z=0\). Does its positive sign rule out defiers?
  4. State what independence requires in terms of \(Z\), \(Y(0)\), \(Y(1)\), \(D(0)\), and \(D(1)\).
  5. Why can observed treatment rates establish relevance but not, by themselves, establish monotonicity?
Clinical Biostats